Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Definitive Healthcare (DH) EBIT Margin (2020 - 2025)

Definitive Healthcare (DH) has disclosed EBIT Margin for 6 consecutive years, with 43.27% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 11657.0% year-over-year to 43.27%, compared with a TTM value of 92.86% through Dec 2025, up 18899.0%, and an annual FY2025 reading of 92.86%, up 18899.0% over the prior year.
  • EBIT Margin was 43.27% for Q4 2025 at Definitive Healthcare, down from 14.47% in the prior quarter.
  • Across five years, EBIT Margin topped out at 6.86% in Q2 2025 and bottomed at 579.95% in Q2 2024.
  • Average EBIT Margin over 5 years is 107.8%, with a median of 21.25% recorded in 2022.
  • The sharpest move saw EBIT Margin plummeted -56014bps in 2024, then surged 57308bps in 2025.
  • Year by year, EBIT Margin stood at 31.33% in 2021, then skyrocketed by 45bps to 17.39% in 2022, then rose by 12bps to 15.29% in 2023, then tumbled by -946bps to 159.84% in 2024, then surged by 73bps to 43.27% in 2025.
  • Business Quant data shows EBIT Margin for DH at 43.27% in Q4 2025, 14.47% in Q3 2025, and 6.86% in Q2 2025.